No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
295 |
4. Check minimum number of eventsNone |
295 |
5. Include endpointsNone |
295 |
6. Filter based on genotype QC (FinnGen only) |
286 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D30
Name in latin
Neoplasma benignum vesicae urinariae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Bladder
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Bladder
- Benign neoplasm of urinary organs
- Benign neoplasm of urinary organs
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2475 | 947 | 1483 |
| Only index persons | 1772 | 757 | 1015 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.03 | 0.04 |
| Only index persons | 0.03 | 0.03 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 63.13 | 60.11 | 64.96 |
| Only index persons | 61.04 | 57.95 | 63.34 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 286 | 100 | 186 |
| Unadjusted period prevalence (%) | 0.07 | 0.04 | 0.09 |
| Median age at first event (years) | 61.84 | 53.59 | 66.28 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_BLADDER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_BLADDER | 1.365 [1.11, 1.68] | 0.004 |
| Birth year | 0.991 [0.98, 1.0] | 0.048 |
During the follow-up period (1.1.1998 — 31.12.2019), 171 out of 564 females with CD2_BENIGN_BLADDER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_BLADDER | 1.415 [1.17, 1.7] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.011 |
During the follow-up period (1.1.1998 — 31.12.2019), 343 out of 846 males with CD2_BENIGN_BLADDER died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_BLADDER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.114% | 0.309% |
| 5 | 0.766% | 1.871% |
| 10 | 1.776% | 4.391% |
| 15 | 3.311% | 8.048% |
| 20 | 5.832% | 13.67% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_BLADDER – Benign neoplasm: Bladder
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data